PMA P860026S006

Device
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE
Applicant
Avery Biomedical Devices, Inc.
PMA number
P860026
Supplement
S006
Product code
GZE
Decision date
2000-07-07
Classification
Implanted Diaphragmatic/phrenic Nerve Stimulator
Generic name
implanted diaphragmatic/phrenic nerve Stimulator
Approval order statement
APPROVAL FOR PROCESS VALIDATION OF THE PROPOSED DEVICE STERILIZATION PROCEDURE, PROPOSED LABELING FOR THE DEVICE PACKAGING, AND THE PROPOSED CHANGES TO THE INSTRUCTION MANUAL. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MARK IV AND IS INDICATED FOR PERSONS WHO REQUIRE CHRONIC VENTILATORY SUPPORT BECAUSE OOF UPPER MOTOR NEURON RESPIRATORY MUSCLE PARALYSIS (RMP) OR BECAUSE OF CENTRAL ALVEOLAR HYPOVENTILATION (CAH) AND WHOSE REMAINING PHRENIC NERVE, LUNG, AND DIAPHRAGM FUNCTION

Current openFDA PMA Record#

Device
DIAPHRAGMATIC PACEMAKER PHRENIC NERVE
Applicant
Avery Biomedical Devices, Inc.
PMA number
P860026
Supplement
S006
Product code
GZE
Generic name
implanted diaphragmatic/phrenic nerve Stimulator
Decision date
2000-07-07
Decision code
APPR
Date received
2000-04-27
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Approval order statement
APPROVAL FOR PROCESS VALIDATION OF THE PROPOSED DEVICE STERILIZATION PROCEDURE, PROPOSED LABELING FOR THE DEVICE PACKAGING, AND THE PROPOSED CHANGES TO THE INSTRUCTION MANUAL. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME MARK IV AND IS INDICATED FOR PERSONS WHO REQUIRE CHRONIC VENTILATORY SUPPORT BECAUSE OOF UPPER MOTOR NEURON RESPIRATORY MUSCLE PARALYSIS (RMP) OR BECAUSE OF CENTRAL ALVEOLAR HYPOVENTILATION (CAH) AND WHOSE REMAINING PHRENIC NERVE, LUNG, AND DIAPHRAGM FUNCTION